147 related articles for article (PubMed ID: 11414699)
1. Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jun; 284(5):1116-25. PubMed ID: 11414699
[TBL] [Abstract][Full Text] [Related]
2. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2001 Jul; 285(1):118-28. PubMed ID: 11437381
[TBL] [Abstract][Full Text] [Related]
3. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
Funasaka T; Haga A; Raz A; Nagase H
Int J Cancer; 2002 Sep; 101(3):217-23. PubMed ID: 12209971
[TBL] [Abstract][Full Text] [Related]
4. Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Yanagawa T; Funasaka T; Tsutsumi S; Watanabe H; Raz A
Endocr Relat Cancer; 2004 Dec; 11(4):749-59. PubMed ID: 15613449
[TBL] [Abstract][Full Text] [Related]
5. Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid.
Funasaka T; Haga A; Raz A; Nagase H
Biochem Biophys Res Commun; 2002 Apr; 293(1):192-200. PubMed ID: 12054583
[TBL] [Abstract][Full Text] [Related]
6. Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
Takanami I; Takeuchi K; Watanabe H; Yanagawa T; Takagishi K
Oncol Rep; 2002; 9(1):125-8. PubMed ID: 11748469
[TBL] [Abstract][Full Text] [Related]
7. [The role of autocrine motility factor receptor in metastasis].
Watanabe H; Chigira M; Raz A
Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
[TBL] [Abstract][Full Text] [Related]
8. Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Torimura T; Ueno T; Kin M; Harada R; Nakamura T; Kawaguchi T; Harada M; Kumashiro R; Watanabe H; Avraham R; Sata M
Hepatology; 2001 Jul; 34(1):62-71. PubMed ID: 11431735
[TBL] [Abstract][Full Text] [Related]
9. Autocrine motility factor is a growth factor.
Silletti S; Raz A
Biochem Biophys Res Commun; 1993 Jul; 194(1):446-57. PubMed ID: 8392842
[TBL] [Abstract][Full Text] [Related]
10. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Silletti S; Timar J; Honn KV; Raz A
Cancer Res; 1994 Nov; 54(22):5752-6. PubMed ID: 7954394
[TBL] [Abstract][Full Text] [Related]
11. [Possibility that AMF will serve as a target molecule for the diagnosis and treatment of a metastatic neoplasm].
Haga A
Yakugaku Zasshi; 2005 Feb; 125(2):169-75. PubMed ID: 15684571
[TBL] [Abstract][Full Text] [Related]
12. Expression of autocrine motility-like factor in rheumatoid synovial fluid.
Watanabe H; Takeuchi K; Chigira M
J Rheumatol; 1994 Jan; 21(1):37-40. PubMed ID: 8151584
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
14. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Silletti S; Yao JP; Pienta KJ; Raz A
Int J Cancer; 1995 Sep; 63(1):100-5. PubMed ID: 7558435
[TBL] [Abstract][Full Text] [Related]
15. Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Silletti S; Paku S; Raz A
Am J Pathol; 1996 May; 148(5):1649-60. PubMed ID: 8623932
[TBL] [Abstract][Full Text] [Related]
16. Activation of small GTPase Rho is required for autocrine motility factor signaling.
Tsutsumi S; Gupta SK; Hogan V; Collard JG; Raz A
Cancer Res; 2002 Aug; 62(15):4484-90. PubMed ID: 12154059
[TBL] [Abstract][Full Text] [Related]
17. The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
Haga A; Tanaka N; Funasaka T; Hashimoto K; Nakamura KT; Watanabe H; Raz A; Nagase H
J Mol Biol; 2006 May; 358(3):741-53. PubMed ID: 16563432
[TBL] [Abstract][Full Text] [Related]
18. The role of autocrine motility factor in tumor and tumor microenvironment.
Funasaka T; Raz A
Cancer Metastasis Rev; 2007 Dec; 26(3-4):725-35. PubMed ID: 17828376
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe H; Takehana K; Date M; Shinozaki T; Raz A
Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049
[TBL] [Abstract][Full Text] [Related]
20. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Nam SW; Clair T; Kim YS; McMarlin A; Schiffmann E; Liotta LA; Stracke ML
Cancer Res; 2001 Sep; 61(18):6938-44. PubMed ID: 11559573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
